Trial intelligence / Profile preview

Sustained-release vs Immediate-release Hydromorphone in Urologic Surgery

NCT05375916Completed

Sponsor
University of Alberta
Start
May 2022
Primary completion
Nov 2023
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, double-blind trial of hydromorphone in acute pain (2 arms), sponsored by University of Alberta. Primary endpoint: Time to Mobilization up to 5 days. Started May 2022; status: completed.

02

Drugs

hydromorphone
03

Conditions

acute pain

Beyond the preview

Go deeper on NCT05375916.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05375916.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call